Botanical Drug Development: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 29, 2016
May 7, 2020
bec78068-96c3-424e-b070-7b4ecfcfc8bf
Related Documents
ANDA Submissions -- Refuse-to-Receive Standards Rev2
Guidance DocumentDecember 28, 2016Center for Drug Evaluation and Research
Regulatory Classification of Pharmaceutical Co-Crystals
Guidance DocumentFebruary 15, 2018Center for Drug Evaluation and Research
SUPAC: Manufacturing Equipment Addendum
Guidance DocumentDecember 2, 2014Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox